Found 86 matching trials
Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients PHASE3 Multiple myeloma is a malignant incurable hematological disease where survi...
Show More Location
Hæmatologisk afdeling B, Aalborg Sygehus Syd
Learn More & Join Trial
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma PHASE2 Patients included in the study will receive induction treatment during 6 mo...
Show More Status
Active Not Recruiting
Location
Hospital Clínic de Barcelona
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Carfilzomib Consolidation Therapy After Autologous Stem Cell Transplantation (ASCT) for Mantle Cell Lymphoma (MCL), T-cell Lymphoma (TCL), and Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 The goal of this clinical research study is to find the highest tolerable d...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Velcade (Bortezomib) Consolidation After Transplant PHASE3 The purpose of this study is to determine if bortezomib when added to conso...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML NA This study evaluates the efficacy and safety of the combination of idarubic...
Show More Location
The First Affiliated Hospital with Nanjing Medical University
Learn More & Join Trial
Therapy for Patients With Untreated Age-Adjusted International Prognostic Index Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B Cell Lymphoma PHASE2 About 60% of patients with DLBCL can be cured with a chemotherapy program. ...
Show More Location
Memorial Sloan Kettering Cancer Center
Treatments Being Tested
Etoposide, carboplatin, ifosfamide Rituximab, Ifosfamide, Etoposide, Carboplatin Rituximab, Ifosfamide, Etoposide, Carboplatin, Stem Cell Collection, Mitoxantrone, Cyclophosphamide and etoposide, Carmustine Learn More & Join Trial
Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 Based on the further need to improve progression-free survival (PFS) and ov...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Treatment of High-risk Newly Diagnosed Multiple Myeloma With Minimal Residual Disease Detection PHASE4 The goal of this study is to evaluate sustained MRD negativity for one year...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma PHASE2 The Cardamon trial is a phase 2 trial using the standard chemotherapy drugs...
Show More Status
Active Not Recruiting
Learn More & Join Trial